Procaps Group, S.A Operating Margin 2020-2023 | PROCF
Current and historical operating margin for Procaps Group, S.A (PROCF) over the last 10 years. The current operating profit margin for Procaps Group, S.A as of September 30, 2023 is 0.00%.
| Procaps Group, S.A Operating Margin Historical Data |
| Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
| 2023-09-30 |
$0.41B |
$0.03B |
7.99% |
| 2023-06-30 |
$0.41B |
$0.04B |
9.14% |
| 2023-03-31 |
$0.41B |
$0.04B |
9.83% |
| 2022-12-31 |
$0.41B |
$0.04B |
9.54% |
| 2022-09-30 |
$0.44B |
$0.07B |
16.78% |
| 2022-06-30 |
$0.43B |
$0.07B |
17.13% |
| 2022-03-31 |
$0.42B |
$0.07B |
17.18% |
| 2021-12-31 |
$0.41B |
$0.07B |
17.07% |
| 2021-09-30 |
$0.54B |
$0.29B |
53.46% |
| 2021-06-30 |
$0.51B |
$0.28B |
55.62% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$0.125B |
$0.410B |
|
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|
